Patricia J McLaughlin

6PUBLICATIONS
4CO-AUTHORS
Medical virologyToxicology (incl. clinical toxicology)Optical technologyIndustrial microbiology (incl. biofeedstocks)Dental therapeutics, pharmacology and toxicology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 04, 2025
Exploring the relationships of physical, mental, and emotional symptoms and serum biomarkers of angiogenesis in multiple sclerosis.

Laura B Odom, Gary A Thomas, Jikku J Zachariah

|Jun 15, 2023
Safety study of topical naltrexone therapy for diabetic skin wounds is confirmed in Göttingen mini-pigs.

Patricia J McLaughlin, Joseph W Sassani, Ian S Zagon

|Nov 18, 2020
Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications.

Ian S Zagon, Joseph W Sassani, Indira Purushothaman

|Jul 10, 2020
Dysregulation of the OGF-OGFr pathway correlates with elevated serum OGF and ocular surface complications in the diabetic rat.

Ian S Zagon, Joseph W Sassani, Indira Purushothaman

|Jan 30, 2019
Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes.

Patricia J McLaughlin, Joseph W Sassani, Michelle B Titunick

|Dec 14, 2018
Intermittent blockade of OGFr and treatment of autoimmune disorders.

Ian S Zagon, Patricia J McLaughlin

Pageof 1